Serum Institute will start phase-III trials after clearances: ICMR on COVID vaccine

Video Credit: ANI
Published on September 15, 2020 - Duration: 01:21s

Serum Institute will start phase-III trials after clearances: ICMR on COVID vaccine

Director General of Indian Council of Medical Research, Balram Bhargava on September 15 informed about the COVID-19 vaccines trial stage in India.

He said, Cadila and Bharat Biotech have completed phase-I trials and Serum Institute has completed phase II-B3 trials, and will start phase-III trials after clearance.

He said, "3 vaccines are at clinical trial stage in India.

Cadila and Bharat Biotech have completed phase-I trials.

Serum Institute has completed phase II-B3 trials, and will start phase-III trial (with 1500 patients at 14 locations) after clearances."


You are here


๐Ÿ’ก newsR Knowledge: Other News Mentions


Coronavirus disease 2019

Infectious respiratory disease caused by severe acute respiratory syndrome coronavirus 2
Security and defence cooperation in the Indo-Pacific region in the face of China's aggressive behavior and public health collaboration with an eye on the ongoing..
Credit: IndiaTimes - Published 3 hours ago

It's starting to make more sense why Khabib Nurmagomedov so badly wants to fight Georges St-Pierre -- it was his father's plan. Khabib's dad, Abdulmanap..
Credit: TMZ.com - Published 10 hours ago


The paper-strip uses cutting-edge CRISPR gene-editing technology to identify and target the genetic material of SARS-CoV-2, the virus that causes Covid-19 in..
Credit: IndiaTimes - Published 1 day ago

The Bharatiya Janata Party (BJP) on Thursday released its manifesto for three-phased Bihar elections and promised that after approval of coronavirus vaccine from..
Credit: DNA - Published 1 day ago

Credit: IndiaTimes - Published 1 day ago

The Indian Council of Medical Research (ICMR) on Thursday issued an advisory on the CRISPR SARS CoV-2 test that has been approved by the Drugs Controller General..
Credit: IndiaTimes - Published 2 days ago

Credit: IndiaTimes - Published 2 days ago


Cadila Healthcare

Indian multinational pharmaceutical company
Besides, Bharat Biotech, Zydus Cadila Ltd is also in Phase 2 of human clinical trials of a COVID-19 vaccine.
Credit: DNA - Published 8 hours ago


Bharat Biotech

Indian biotechnology company and vaccine manufacturer
Credit: IndiaTimes - Published 1 day ago

The recommendation was given by the panel after assessing the data of phase 1 and 2 clinical trials as well as animal challenge study.
Credit: DNA - Published 2 days ago

Related news from verified sources

The phase-III human clinical trial of the Covid-19 vaccine being developed by Oxford University, and manufactured by the Serum Institute of India, began at the...
on September 21, 2020 • IndiaTimes

Codagenix Inc said on Tuesday Serum Institute of India has started manufacturing the US biotech firm's potential Covid-19 vaccine and it expects to begin...
on September 22, 2020 • IndiaTimes

Related videos from verified sources

AstraZeneca's Coronavirus Vaccine Trial Can Continue In The US 00:32
Video credit: Wochit Business - Published 19 hours ago 

Cincinnati 12-year-old takes part in COVID-19 vaccine trial 02:16
Video credit: WCPO Cincinnati - Published 1 day ago 

The science behind 'Challenge Trials' 01:21
Video credit: ABC15 Arizona - Published 2 days ago 

You might like